BioCorRx Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioCorRx Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q3 2024.
  • BioCorRx Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $29.3K, a 80.6% increase year-over-year.
  • BioCorRx Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $124K, a 83.3% increase year-over-year.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2023 was $63.9K, a 42.4% decline from 2022.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2022 was $111K, a 1175% increase from 2021.
  • BioCorRx Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.72K, a 88.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $124K $29.3K +$13.1K +80.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $111K $30.5K +$14.5K +91.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $96.3K $48.5K +$32.4K +201% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $63.9K $15.7K -$3.67K -18.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $67.6K $16.2K -$7.12K -30.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $74.7K $16K +$458 +2.96% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $74.3K $16.1K -$36.8K -69.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $111K $19.4K +$19.4K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $91.7K $23.3K +$23.3K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $68.4K $15.5K +$11.8K +320% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $56.6K $52.9K +$47.9K +952% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $8.72K $0 -$11K -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $19.7K $0 -$7.83K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $27.5K $3.69K -$5.52K -59.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $33K $5.03K -$43.7K -89.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $76.8K $11K -$18.1K -62.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $94.8K $7.83K -$3.86K -33% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $98.7K $9.2K -$694K -98.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $793K $48.8K -$902K -94.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.69M $29K -$1.21M -97.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $2.91M $11.7K -$939K -98.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $3.85M $703K +$625K +795% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $3.22M $951K +$872K +1111% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $2.35M $1.24M +$1.16M +1481% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.19M $951K +$867K +1034% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $319K $78.5K -$1 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $319K $78.5K $0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $319K $78.5K $0 0% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 $319K $83.9K +$5.32K +6.77% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $314K $78.5K +$52.4K +200% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $262K $78.5K +$78.5K Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $183K $78.5K Oct 1, 2016 Dec 31, 2016 10-K 2017-04-13
Q3 2016 $78.5K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $26.2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.